Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00125
|
|||||
| EM Name |
Tetranor-prostaglandin EM
|
|||||
| Synonyms |
Hdopnp; tetranor-PGEM; PGE-Mum; Tetranor-Prostaglandin EM; 8-[(1r,2r,5r)-2-(2-carboxyethyl)-5-hydroxy-3-oxocyclopentyl]-6-oxooctanoic acid; 11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostan-1,20-dioic acid; 11alpha-Hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostanoic acid; prostaglandin E-M; prostaglandin E2-M; prostaglandin E2-UM; prostaglandin E2-Mum; AC1L4PHI; PGE2-UM; AC1Q5W1Q; SCHEMBL347438; CTK4F4370; prostaglandin E2 urinary metabolite; ZINC5157264; LMFA03010032; SR-01000946844
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=161468"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H24O7
|
|||||
| Canonical SMILES |
C1C(C(C(C1=O)CCC(=O)O)CCC(=O)CCCCC(=O)O)O
|
|||||
| InChI |
InChI=1S/C16H24O7/c17-10(3-1-2-4-15(20)21)5-6-11-12(7-8-16(22)23)14(19)9-13(11)18/h11-13,18H,1-9H2,(H,20,21)(H,22,23)/t11-,12-,13-/m1/s1
|
|||||
| InChIKey |
ZJAZCYLYLVCSNH-JHJVBQTASA-N
|
|||||
| CAS Number |
CAS 24769-56-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 328.36 | Topological Polar Surface Area | 129 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 11 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 7 | |||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:73965
|
|||||
| DT(s) "handling" This EM | OATP2A1 | Transporter Info | Organic anion transporting polypeptide 2A1 | [1] | ||
| References | ||||||
| 1 | Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia. J Clin Invest. 2017 Sep 1;127(9):3367-3374. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.